Needs for biological risk assessment in interspecies extrapolation.

Area of Science:

• Toxicology
• Risk Assessment
• Carcinogenesis

Background:

• Animal studies are crucial for identifying potential human carcinogens.
• However, extrapolating animal carcinogenicity data to human risk at low exposure levels presents challenges.
• High-dose toxicity and high background tumor rates in animal models can complicate risk assessment.

Purpose of the Study:

• To propose a framework for re-evaluating chemical carcinogenicity based on interspecies differences.
• To identify specific experimental conditions that warrant cautious interpretation of animal carcinogenicity data for human risk.
• To emphasize the role of Biological Risk Assessment in refining human health risk evaluations.

Main Methods:

• Application of Biological Risk Assessment principles to existing experimental carcinogenicity data.
• Analysis of factors such as high background tumor yields and high-dose toxicity in animal models.
• Comparative analysis of chemical effects across species.

Main Results:

• Demonstrated that not all chemicals carcinogenic in animals are necessarily potent human carcinogens at low exposure levels.
• Identified specific experimental scenarios (high background tumors, high-dose toxicity) where animal data requires careful scrutiny for human relevance.
• Highlighted the potential for Biological Risk Assessment to differentiate between human and animal carcinogenic responses.

Conclusions:

• Chemicals showing carcinogenicity in animal models may not pose a significant risk to humans at lower exposure levels.
• Biological Risk Assessment is a valuable tool for identifying and evaluating chemicals with potential interspecies differences in carcinogenic effects.
• Careful consideration of experimental conditions, such as high background tumor rates and high-dose toxicity, is essential before assuming human carcinogenicity.